Johns Hopkins Internal Medicine at Green Spring Station
Lutherville, Maryland, 21093, United States
NCT Number: NCT06358261
The investigators overarching goal is to increase the percentage of patients engaging in diabetes prevention activities to reduce the incidence of diabetes. The investigators objective is to design and pilot test a prediabetes clinical decision support (CDS) tool in the electronic health record (EHR) that will assess the patient's activation level based on responses to a questionnaire. Based on the patient's assessed level of activation, the tool will generate several communication recommendations to guide clinicians in conversations related to prediabetes/lifestyle change and tailor recommendations about available resources (e.g., care manager, health coach, DPP) to support patient activation.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Lutherville, Maryland, 21093, United States
Patient activation, which incorporates elements of self-efficacy and readiness to change, is particularly important in managing conditions like pre-diabetes, where the mainstay of treatment is behavioral lifestyle change and self-management. Unfortunately, Primary Care Physicians (PCPs) often do not have adequate training on how to promote patient activation. Traditionally, patient decision aids are used in shared decision-making to help elicit patient preferences and guide treatment options. However, the guides primarily focus on reviewing treatment options rather than increasing patient activation, which is key to successful and efficient behavioral counseling. The Patient Activation Measure (PAM) is a widely used and validated patient-reported outcome measure for assessing patient activation. Studies have demonstrated that using PAM to tailor care to a patient's activation level decreased health service utilization while improving clinical outcomes like blood pressure and self-management behaviors.
The investigators overarching goal is to increase the percentage of patients engaging in diabetes prevention activities to reduce the incidence of diabetes. The investigators objective is to design and pilot test a pre-diabetes clinical decision support (CDS) tool in the electronic health record (EHR) that will assess the patient's activation level based on responses to a questionnaire. Based on the patient's assessed level of activation, the tool will generate several communication recommendations to guide clinicians in conversations related to pre-diabetes/lifestyle change and tailor recommendations about available resources (e.g., care manager, health coach, DPP) to support patient activation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diabetes Prevention Patient Activation Clinical Decision Support Tool will be used by the doctor during the visit to discuss lifestyle management
Time frame: baseline, 6 months
measured by Patient Activation Measure (PAM) survey, a 13-item scale with 4 Likert response,s and scores ranging from 0 to 100 (higher score means higher activation level)
Time frame: baseline, 6 months
measured using electronic health record data
Time frame: baseline, 6 months
measured using electronic health record data
Time frame: baseline, 6 months
measured using survey developed by study team will assess what diet changes participants have made
Time frame: baseline, 6 months
measured using survey developed by study team will assess the change in amount and frequency of physical activity that participants have made
Johns Hopkins University
Other
Pilot Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT06116149
Body Weight, Diabetes Mellitus
New Orleans, Louisiana, United States
View Trial DetailsNCT05358444
Body Weight, Diabetes Mellitus
Baltimore, Maryland, United States
View Trial DetailsNCT07488767
Diabetes Mellitus, Endocrine System Diseases
New York, United States
View Trial Details